Form 4: Synchrony Financial Director Ellen M. Zane Reports Dividend Equivalent Unit Acquisition
SEC Form 4 Filing
Director Ellen M. Zane reports the acquisition of dividend equivalent units related to restricted stock units in Synchrony Financial.
Summary
- On February 18, 2025, Ellen M. Zane, a director of Synchrony Financial, acquired 13 dividend equivalent units.
- These units were accrued as dividends paid on common shares underlying restricted stock units.
- The dividend equivalent units vest proportionately with and are subject to settlement and expiration under the same terms as the related restricted stock units.
- Each dividend equivalent unit represents the economic equivalent of one share of Synchrony Financial common stock.
- Following the transaction, Ms. Zane directly owns 27,183 dividend equivalent units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a neutral sentiment. It simply reports a transaction.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The acquisition of dividend equivalent units by a director may be of interest to shareholders as it reflects changes in insider ownership.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of transaction: Acquisition of dividend equivalent units. |
| 02/20/2025 | Date of signature on the Form 4 filing. |
Keywords
Synchrony Financial, Director, Ellen M. Zane, Dividend Equivalent Units, Restricted Stock Units, Beneficial Ownership, Form 4, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.